Cipla Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
819 result(s) found, displaying 41 to 50
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APIXAIR apixaban 5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XABANIL apixaban 2.5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XABANIL apixaban 5 mg tablet blister pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Prescription medicine registrationActive ingredients: Teriparatide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SALPLUSF DPI 500/50 fluticasone propionate 500 microgram / salmeterol (as xinfoate) 50 microgram powder for inhalation blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA PALBOCICLIB 125 palbociclib 125 mg capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA PALBOCICLIB 75 palbociclib 75 mg capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA PALBOCICLIB 100 palbociclib 100 mg capsule bottle.